Sellas life sciences group inc

Major-Pharmaceuticals

SLS


15 West 38th Street
New York , NY 10018

Executive/
Director

Price

  • Last Close
  • $ 1.3
    $ -0.01 -0.76 %
    Aug 29, 2024
  • 52-Week High/Low
  • $1.82 - $0.51
  • YTD
  • 22.6%

  • Trading Volume
  • 5,127
  • Market Cap Full
  • $ 41.7M
  • Shares Outstanding
  • 32.1M
    Nov 8, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - -17.1% -5% 49.1% 20.8% -39.4% -4.7%
Q2 48.7% 48.7% 48.7% -60.5% -89.2% 4% 30% -66.6% 9.8% 10.3%
Q3 48.7% 48.7% 48.7% -64.6% 8% 8% -17.5% -9.4% 4.5% -
Q4 48.7% 48.7% 48.7% 4.2% 3346.3% 129.1% -39.6% 16.8% -32.5% -
J F M A M J J A S O N D
2024 -39.6% 57.8% - 16.8% - - - - - - - -
2023 40.7% -49.1% -15.4% -1.8% 22.1% -8.5% 4.5% -10.4% 11.6% -40.9% 7.2% 1.9%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%239%37%-3%-57%-55%23%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.09 0.07 0.09 -1.67 -0.22 -0.66 -0.16 -1.05 -0.47
Q2 0.07 0.06 0.16 -1.26 -0.13 -0.66 -0.3 -0.41 -0.31
Q3 0.04 0.02 0.15 -0.53 -2.68 -0.53 -0.45 -0.34 -0.33
Q4 0.08 0.58 - 0.31 9.21 -0.26 -0.43 -0.33 -
A 0.3 0.7 0.4 -3.2 6.2 -2.1 -1.3 -2.1 -1.11

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 23.2 6.7 15.1 15.9 28.3
Jun 6.7 25.2 6.7 15.1 20.5 28.3
Sep 19.6 226.5 9.5 15.9 20.6 28.3
Dec 22 4.9 9.5 15.9 20.6 32.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - 8 0.3 - -
Total Asset Turnover 0.1 0.3 - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 42 6.3 - 20 10.3
Equity multiplier - 0.1 0.2 1 1.8